Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Menthol with Mannitol for Painful Diabetic Peripheral Neuropathy
NCT02728687Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2017
- Primary completion
- Mar 2020
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bronchitol in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by University of British Columbia. Primary endpoint: Brief Pain Inventory pain interference score at 3 months. Started Mar 2017; status: completed.
02
Drugs
Bronchitol
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02728687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02728687.